Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Metlifecare's Enterprise Value for the quarter that ended in Jun. 2020 was A$0.00 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metlifecare's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was A$-51.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metlifecare EV-to-EBIT Related Terms
Metlifecare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Metlifecare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Metlifecare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metlifecare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Metlifecare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Metlifecare's EV-to-EBIT falls into.
Metlifecare's current Enterprise Value is A$1,200.84 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metlifecare's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was A$-51.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metlifecare (ASX:MEQ) has a EV-to-EBIT of -23.25 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Metlifecare and its competitors.
Is Metlifecare's EV-to-EBIT too high?
Metlifecare's current EV-to-EBIT is -23.25. Overall, Metlifecare has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metlifecare's EV-to-EBIT compare to HCA and DVA?
Metlifecare's EV-to-EBIT of -23.25 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBIT is 15.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Metlifecare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metlifecare's current EV-to-EBIT is -23.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metlifecare stock overvalued right now?
Metlifecare (ASX:MEQ) has a current EV-to-EBIT of -23.25. The current EV-to-EBIT is -23.25. Metlifecare's overall GF Score™ is 4/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Metlifecare (ASX:MEQ), the current EV-to-EBIT is -23.25 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metlifecare Ltd operates retirement communities throughout New Zealand. It generates revenue from membership fees and rest home, hospital and service, and village fees. Metlifecare's membership fees are paid by residents of independent living units and serviced apartments and allow residents to use common facilities. Its largest single customer is the New Zealand government, which pays fees on behalf of residents eligible for government subsidized elderly care. The majority of Metlifecare's retirement villages are located in Auckland.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MEQ has been successfully added to your 
